- Research works
- 36 ▲ 112% vs 2018-21
- Citations
- 1.2k 34.8 per fractional work
- Top-10% rate
- 13.2% all institutions 10.0%
- Open access
- 39% world 40%
- International
- 12% world 18%
Not ranked overall: Ambrx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Ambrx (United States) work in?
In all years, 58% of research at Ambrx (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (4%). It does 2.1× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 13 fields, with their numbers
- Health Sciences2157.8%
- Life Sciences1234.2%
- Social Sciences14.0%
- Physical Sciences14.0%
- Chemistry12.1%
- Computer Science01.1%
- Materials Science00.5%
- Engineering00.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.
All 8 fields, with their numbers
- Immunology and Microbiology6.16×1 works
- Medicine3.21×7 works
- Biochemistry, Genetics and Molecular Biology2.62×2 works
- Business, Management and Accounting1.24×0 works
- Social Sciences0.71×1 works
- Computer Science0.45×0 works
- Agricultural and Biological Sciences0.21×0 works
- Engineering0.05×0 works
Who are the top researchers at Ambrx (United States)?
Ranked on the quality score, Sandra Lyn Biroc, Nick A. Knudsen and Jason K. Pinkstaff lead among researchers whose main affiliation is Ambrx (United States).
- 1
Sandra Lyn Biroc
United States · #602,779 worldwide 2.7k citations · 41 works
- 2
Nick A. Knudsen
United States · #619,001 worldwide 867 citations · 31 works
- 3
Jason K. Pinkstaff
United States · #788,842 worldwide 2.3k citations · 41 works
- 4
Anthony Manibusan
United States · #870,614 worldwide 1.1k citations · 20 works
- 5
Lillian K. Skidmore
United States · #1,282,039 worldwide 438 citations · 47 works
Which keywords describe research at Ambrx (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Monoclonal Antibody, Breast Cancer and Chemotherapy.
- Tumor Targeting
- Human Rights
- Constitutional Law
- Bacterial Therapy
- DNA nanotechnology
- Self-Assembly
- Chimeric Antigen Receptor
- Biopharmaceuticals
- Angiogenesis
- Cancer Therapy
- Radioimmunotherapy
- Targeted Therapy
- Inflammation
- Tumor Regression
- Cancer
- Trastuzumab
- Chemotherapy
- Monoclonal Antibody
- Antibody Engineering
- Glycosylation
- Monoclonal Antibodies
- Therapeutic Antibodies
- Fc Receptors
- Breast Cancer
- HER2
- Immunotherapy
- PET Imaging
- Lymphoma
- Cancer Treatment
- Gene Therapy
- Radiopharmaceuticals
- Cancer Immunotherapy
- Apoptosis
- CAR T Cells
- Immunogenicity
- Biosensors
- Extracellular Matrix
- Cell Death
- Genetic Mutations
- Mitochondria
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Monoclonal Antibodies7▲ 140×3 topics
- Glycosylation7▲ 84×3 topics
- Therapeutic Antibodies6▲ 142×2 topics
- Antibody Engineering6▲ 165×1 topic
- Fc Receptors6▲ 165×1 topic
- Monoclonal Antibody5▲ 189×2 topics
- Breast Cancer5▲ 46×2 topics
- Chemotherapy4▲ 17×2 topics
- HER24▲ 388×1 topic
- Trastuzumab4▲ 275×1 topic
- Immunotherapy4▲ 15×5 topics
- Cancer2▲ 5.0×10 topics
- PET Imaging2▲ 31×2 topics
- Tumor Regression2▲ 74×2 topics
- Lymphoma2▲ 37×2 topics
- Inflammation2▲ 2.3×8 topics
- Cancer Treatment2▲ 19×2 topics
- Targeted Therapy2▲ 23×2 topics
- Gene Therapy2▲ 18×4 topics
- Radioimmunotherapy2▲ 123×1 topic
- Radiopharmaceuticals2▲ 123×1 topic
- Cancer Therapy2▲ 7.0×3 topics
- Cancer Immunotherapy1▲ 27×2 topics
- Angiogenesis1▲ 9.1×4 topics
- Apoptosis1▲ 9.4×2 topics
- Biopharmaceuticals1▲ 52×2 topics
- CAR T Cells1▲ 84×1 topic
- Chimeric Antigen Receptor1▲ 84×1 topic
- Immunogenicity1▲ 70×2 topics
- Self-Assembly1▲ 9.1×2 topics
- Biosensors1▲ 5.9×1 topic
- DNA nanotechnology1▲ 33×1 topic
- Extracellular Matrix1▲ 12×2 topics
- Bacterial Therapy1▲ 64×1 topic
- Cell Death1▲ 14×2 topics
- Constitutional Law1▲ 21×1 topic
- Genetic Mutations1▲ 5.4×2 topics
- Human Rights1▲ 3.3×1 topic
- Mitochondria1▲ 17×2 topics
- Tumor Targeting1▲ 21×1 topic
Which research topics does Ambrx (United States) publish most on?
By volume in 2022-now: Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Brazilian Legal Issues.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 HER2/EGFR in Cancer Research Oncology 1 works
- 4 Brazilian Legal Issues Law 1 works
- 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 6 CAR-T cell therapy research Oncology 1 works
- 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 8 Protein purification and stability Molecular Biology 0 works
- 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 10 Immune Cell Function and Interaction Immunology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Ambrx (United States)'s research output changed?
Output in 2022-2025 was 112% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Ambrx (United States) as a percentage of every work published that year, 0.000031% in 2024.
Fractional works of Ambrx (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in La Jolla
- Salk Institute for Biological Studies
- Sanford Burnham Prebys Medical Discovery Institute
- National University
- Neurosciences Institute
- La Jolla Alcohol Research
- Behavioral Pharma (United States)
- J. Craig Venter Institute
- Biomedical Research Laboratories (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Ambrx (United States). Posts are plain text and can be reported.